PPAR Delta as a Therapeutic Target in Triple-negative Breast Cancers
Abstract
PPAR is a member of peroxisome proliferators activated receptors which play important role in regulating cellular metabolisms. Basal-like breast cancers accounting for ~15% of all breast cancer cases tend to be very aggressive and have poor prognosis. Basal-like breast cancers are considered to be derived from mammary stem cells. Abnormal activation of Wnt signaling is often found in human basal-like breast cancers. Here we report that PPAR expression is induced by Wnt signaling in mammary stem cells. Activation of PPAR by its ligands and fatty acids promotes the proliferation of mammary stem cells. Activation of PPAR induces the proliferation of mammary cancer stem cells. PPAR agonist accelerates the onset of tumors and increases the growth rate of tumors in MMTV-Wnt1 transgenic. We also found that PPAR antagonist inhibits the proliferation and anchorage-independent growth of a human basal-like breast cancer cell line.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2011
- Accession Number
- ADA560836
Entities
People
- Chao Qi
Organizations
- Northwestern University